Big pharma deal: Bristol-Myers Squibb to buy Celgene
3:16
Big pharma deal: Bristol-Myers Squibb to buy Celgene
Jan 3, 2019
CNN
Celgene Corporation completed the acquisition of EngMab AG for CHF 3 billion.
Celgene Corporation completed the acquisition of EngMab AG for CHF 3 billion.
Sep 26, 2016
marketscreener.com
Celgene Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2019
Celgene Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2019
Oct 31, 2019
marketscreener.com
Summit-based Celgene Sold For $74 Billion
Summit-based Celgene Sold For $74 Billion
Jan 3, 2019
patch.com
Whistleblower Claims Celgene Colluded With Charities to Drive Profits
$
Whistleblower Claims Celgene Colluded With Charities to Drive Profits
Aug 1, 2016
FortuneSy Mukherjee
Celgene bet $1 billion that this biotech’s science can cure deadly cancers
$
Celgene bet $1 billion that this biotech’s science can cure deadly cancers
Jun 30, 2015
FortuneLaura Lorenzetti
Rising through the ranks: Interview with Celgene CEO Mark Alles
Rising through the ranks: Interview with Celgene CEO Mark Alles
Apr 5, 2016
thestreet.com
$
Bristol-Myers Squibb Loses $6 Billion in Value on Celgene Deal Setback: Brainstorm Health
Jun 24, 2019
FortuneSy Mukherjee
4:28
Celgene takes new approach to multiple myeloma treatment
Dec 11, 2017
CNBC
1:37
We See a Solid Pipeline for Undervalued Celgene
Nov 7, 2018
morningstar.com
$
U.S. Biotech Firm Celgene to Buy Impact Biomedicines for up to $7 Billion
Jan 8, 2018
FortuneReuters
2:31
Celgene buyers going to do great, says Jim Cramer
Jan 7, 2019
CNBC
BMS compra Celgene por US$ 74.000 millones y crea un gigante mundial de la industria biofarmacéutica
Jan 3, 2019
rpp.pe
2:45
Should a value investor sell Celgene? That and more in #AskHalftime
Jan 25, 2019
CNBC
Biogen, Celgene Close Higher on Earnings; Ford's Acquisitions Do Little to Move Stock -- ICYMI
Dec 7, 2019
thestreet.com
4:35
Celgene chief Alles discusses deal to acquire Impact Biomedicines, strategy for 2018
Jan 8, 2018
CNBC
6:00
Digging into Deals: Why Celgene Joined Up With Juno Therapeutics In 2015
Jan 18, 2016
YahooThe Motley Fool Videos
Principal Scientist, Translational Development – Celgene, New Jersey
Jun 16, 2017
vanderbilt.edu
2:21
Celgene CEO: Creating a great future
Jan 12, 2015
CNBCMeg Tirrell
4:03
Celgene CEO: There's nothing like pipeline success to reverse sentiment
Jun 4, 2018
CNBC
Biofarmacéutica Celgene inicia operaciones en México
Jul 14, 2015
eleconomista.com.mx
Celgene vend un médicament phare à Amgen pour fusionner avec BMS
Aug 26, 2019
lesechos.fr
2:49
Buy Disney ahead of earnings? Has Celgene bottomed, and more
Aug 1, 2018
CNBC
3:50
Bristol-Myers, Celgene deal in focus
Jan 24, 2019
CNBC
Celgene Shareholders Excited by CAR-T News | The Motley Fool
Dec 19, 2017
fool.com
Should You Buy Celgene Stock? | The Motley Fool
Jun 15, 2018
fool.com
7:48
Celgene deal is a 'bold' move, says former Medtronic CEO
Jan 3, 2019
CNBC
Celgene Makes $9 Billion Cancer Treatment Play for Juno Therapeutics
Mar 7, 2024
thestreet.com
0:30
Celgene to buy Receptos for $7.3B
Jul 14, 2015
CNBCReem Nasr
5:53
Bristol-Myers-Celgene acquisition is just the start of pharmaceutical industry mergers, says analyst
Jan 3, 2019
CNBC
See more
Static thumbnail place holder